NYU Abu Dhabi Study Reveals Complex Cellular Responses to Cancer-causing Gene
NYU Abu Dhabi researchers have discovered a complex phenomenon where a single cancer-causing gene can elicit different responses in cells, some promoting tumor suppression and others potentially contributing to cancer development.
Understanding Cellular Senescence
The study, published in EMBO Reports, explores the diverse nature of cellular senescence, a natural defense mechanism where damaged cells stop dividing to prevent cancer. The researchers utilized a zebrafish model of liver cancer to uncover the initial cellular responses to a cancer-causing gene.
They found that precancerous cells exhibit various forms of senescence, with some being terminally senescent, meaning they cannot form tumors, while others regain the ability to divide, potentially leading to cancer. This discovery has implications for understanding how cancer cells evade senescence-inducing treatments like chemotherapy.
Targeting Senescent Cells
Common chemotherapies often induce senescence in cancer cells, but they do not eliminate all senescent cells. Senolytics, a class of drugs, are used to target and remove these therapy-induced senescent cells. The study tested a common senolytic and found it effective against only some precancerous cells, highlighting the need to consider the diverse behavior of senescent cells when developing cancer therapies.
Notable Findings and Implications
- Different Types of Senescence: The study reveals that the type of cellular senescence acquired by precancerous cells matters, with distinct outcomes for tumor formation.
- Varied Sensitivity to Treatments: Senescent cells exhibit varying responses to senolytics, indicating the need for personalized treatment approaches.
- Undergraduate Research Involvement: The research was conducted by NYU Abu Dhabi researchers in collaboration with the University's Center for Genomics and Systems Biology, with several undergraduate students contributing through their capstone research projects.
Professor Kirsten Sadler Edepli from NYU Abu Dhabi emphasizes the significance of these findings:
"Cancer is not merely a question of cell division cessation or continuation. Our study demonstrates the existence of diverse cellular senescence types, with distinct outcomes depending on the senescence form. These findings are crucial for developing targeted cancer therapies, considering the varying responses of senescent cells to treatments."
This research offers valuable insights into the complex interactions within cells, potentially paving the way for more effective cancer treatment strategies.